Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Merck Struggles to Win European Approval for Covid-19 Antiviral Pill

-FT https://www.ft.com/content/2cf0b6cc-b07b-4ff9-a833-42eb1798a576

byCharles Gross

February 16, 2022

1 minute read

-FT

https://www.ft.com/content/2cf0b6cc-b07b-4ff9-a833-42eb1798a576

News

Faraday Future Ships Latest Production-Intent FF 91 Futurist to China for Final Evaluation and Testing

By Benzinga Newsdesk

Today, 5:53 AM

Faraday Future Intelligent Electric, Inc. (NASDAQ:FFIE), ("FF" or the "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced it has shipped one

FFIE

Dragonfly Energy Inks Battery Supply Agreement with Thor Industries’ Keystone RV

By Shivani Kumaresan

Today, 5:53 AM

Nevada-based Lithium-ion battery technology company Dragonfly Energy Corp. has entered into an exclusive agreement with Keystone RV Company,…

THO

Jim Cramer Says People Need To Know About Biohaven

By Adam Eckert

Today, 5:53 AM

Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) announced Wednesday that it has preliminary net revenue of approximately $93 million for its NURTEC ODT product in the second quarter of 2021.

BHVN

Raymond James Upgrades Integral Ad Science to Strong Buy, Raises Price Target to $27

By Benzinga Newsdesk

Today, 5:53 AM

Raymond James analyst Andrew Marok upgrades Integral Ad Science (NASDAQ:IAS) from Outperform to Strong Buy and raises the price target from $26 to $27.

IAS

Merck Struggles to Win European Approval for Covid-19 Antiviral Pill

Related Posts

Faraday Future Ships Latest Production-Intent FF 91 Futurist to China for Final Evaluation and Testing

Dragonfly Energy Inks Battery Supply Agreement with Thor Industries’ Keystone RV

Jim Cramer Says People Need To Know About Biohaven

Raymond James Upgrades Integral Ad Science to Strong Buy, Raises Price Target to $27